University of Glasgow | GenomeWeb

University of Glasgow

Researchers profiling pancreatic neuroendocrine tumors detected inherited cancer-related mutations in nearly one-fifth of affected individuals.

The Stoller Biomarker Discovery Centre, funded by the UK's Medical Research Council, recently opened to develop mass spec-based research for varied diseases.

The node will act as a center for molecular diagnostics research, discovery, and development, and will integrate with existing initiatives.

Using genomic and other technologies, researchers will develop tools to identify HAIs, identify patients at risk for them, and investigate more effective use of antibiotics. 

The universities are partnering with Illumina to supply next-generation sequencing instruments to drive research in cancer, personalized medicine, and agriculture.

NEW YORK (GenomeWeb News) – The University of Glasgow said yesterday it will use £3 million ($5 million) from the Scottish government to support a new imaging center and stratified medicine clinical research program.

NEW YORK (GenomeWeb News) – Oxford BioDynamics and the University of Glasgow today announced a partnership to identify biomarkers for the differentiation of responders from non-responders to methotrexate in the treatment of rheumatoid arthritis.

Miragen Therapeutics said this week that it has taken an exclusive license to intellectual property held by the University of Glasgow that is related to the use of microRNA-145 in the treatment of pulmonary arterial hypertension.
Terms of the deal were not disclosed.

Paired Ends

Premium

Greg Porreca, Adam Cohen, David Cumming, Michael Deem, Jim Lupski, Amy McGuire, Antoine van Oijen, Ian Ratcliffe

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.